SCHRODER INVESTMENT MANAGEMENT GROUP - IONIS PHARMACEUTICALS INC ownership

IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 381 filers reported holding IONIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
SCHRODER INVESTMENT MANAGEMENT GROUP ownership history of IONIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$26,000
-72.3%
589
-64.5%
0.00%
Q4 2020$94,000
+118.6%
1,658
+75.1%
0.00%
Q3 2020$43,000
-42.7%
947
-25.6%
0.00%
Q2 2020$75,000
+5.6%
1,272
-8.6%
0.00%
Q1 2020$71,000
-93.6%
1,392
-92.5%
0.00%
-100.0%
Q3 2019$1,101,000
+18.4%
18,647
+62.7%
0.00%0.0%
Q1 2019$930,000
+43.5%
11,460
-4.4%
0.00%
+100.0%
Q4 2018$648,000
-10.7%
11,984
-14.9%
0.00%0.0%
Q3 2018$726,000
+172.9%
14,080
+179.0%
0.00%
Q3 2017$266,000
-33.7%
5,047
-34.9%
0.00%
-100.0%
Q2 2017$401,0007,7490.00%
Other shareholders
IONIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Tweedy, Browne Co LLC 3,541,136$133,7497.12%
Bellevue Group AG 9,743,900$368,027,1034.88%
M28 Capital Management LP 126,300$4,770,3514.55%
Sicart Associates LLC 246,258$9,301,1653.28%
Camber Capital Management LP 1,925,000$72,7072.49%
Privium Fund Management B.V. 148,807$5,557,9412.11%
Deep Track Capital, LP 1,205,773$45,542,0461.91%
BVF INC/IL 1,121,809$42,370,7261.79%
Orbimed Advisors 1,993,600$75,298,2721.44%
Parkman Healthcare Partners LLC 141,115$5,329,9141.42%
View complete list of IONIS PHARMACEUTICALS INC shareholders